Burden of enthesitis on the quality of life and work productivity in psoriatic arthritis patients

Egyptian Rheumatology and Rehabilitation

Table 7 Multivariate analysis of risk factors in patients with impaired work productivity

Items	B	SE	Wald	df	Sig.	Exp(B)	95% CI for EXP(B)
Items	B	SE	Wald	df	Sig.	Exp(B)	Lower	Upper
Gender	−0.129	0.673	0.037	1	0.848	0.879	0.235	3.285
Axial arthritis	−0.375	0.728	0.265	1	0.607	0.687	0.165	2.863
SPARCC index	0.977	0.517	3.562	1	0.04*	2.656	1.1	7.323
Dactylitis	−0.128	0.889	0.021	1	0.885	0.879	0.154	5.024
Nail psoriasis	0.780	0.836	0.869	1	0.351	2.181	0.423	11.239
PASI	0.006	0.032	0.031	1	0.860	1.006	0.945	1.071
PSAID	−0.395	0.427	0.858	1	0.354	0.673	0.292	1.555
DAPSA	0.054	.066	0.683	1	0.409	1.056	0.928	1.201

DAPSA Disease activity in psoriatic arthritis disease, PASI Psoriasis Area and Severity Index, PSAID Psoriatic arthritis impact of disease, SPARCC index Spondyloarthritis Research Consortium of Canada index, *P ≤ 0.05 = significant